Regarding the intratumoral topographic distribution of PTEN immunostaining in tumor sections, 15/37 (40.5%) cases showed a diffuse positivity, corresponding all of them to gliomas with high PTEN expression (19/37) (Figure 3A). This evidence concerns the gene PTEN and central nervous system cancer.